Browse by all authors Browse By Author Name - Vari,+F.

Browse Results (10 results found)

Subscribe to the RSS feed for this result setSubscribe to the RSS feed for this result set

  Abstract Views File Downloads Thomson Reuters Web of Science Citation Count Scopus Citation Count Altmetric Score
Vari, F., Rossetti, T., Prue, R., Mahler, S. and Hart, D.N. (2006). A CMRF-56 blood dendritic cell preparation loaded with control and tumour-associated antigens, for the immune therapy of multiple myeloma: Transition to a phase I clinical trial. In: Abstracts. x, x, (). x. 120   0
Kobayashi, S, Goto, S, Lord, R, Shimizu, Y, Swanson, C, Vari, F, Edwards-Smith, C, Chiba, S, Pan, TL and Chen, CL (1998) Analysis of immunosuppressive proteins in serum of liver-transplanted rats by using an anti-LSF-1 affinity column. Journal of Surgical Research, 80 1: 58-61. doi:10.1006/jsre.1998.5327 65   2 0
Prue R.L., Vari F., Radford K.J., Tong H., Hardy M.Y., D'Rozario R., Waterhouse N.J., Rossetti T., Coleman R., Tracey C., Goossen H., Gounder V., Crosbie G., Hancock S., Diaz-Guilas S., Mainwaring P., Swindle P. and Hart D.N.J. (2015) A phase i clinical trial of CD1c (BDCA-1)+ dendritic cells pulsed with HLA-A∗0201 peptides for immunotherapy of metastatic hormone refractory prostate cancer. Journal of Immunotherapy, 38 2: 71-76. doi:10.1097/CJI.0000000000000063 6   Cited 0 times in Scopus0 4
Vari, F. and Gandhi, M.K. (2011) Broad-spectrum immunosuppression by classless monocytes in non-Hodgkin's lymphoma. Immunotherapy, 3 6: 723-726. doi:10.2217/IMT.11.56 53   0 Cited 0 times in Scopus0 1
Freeman, J. L., Vari, F. and Hart, D. N. J. (2007) CMRF-56 immunoselected blood dendritic cell preparations activated with GIVI-CSF induce potent antimyeloma cytotoxic T-cell responses. Journal of Immunotherapy, 30 7: 740-748. doi:10.1097/CJI.0b013e31814fb2d6 64   3 Cited 2 times in Scopus2 1
Nourse, J.P., Crooks, P., Keane, C.., Nguyen-Van, D., Mujaj, S., Ross, N., Jones, K., Vari, F., Han, E., Trappe, R., Fink, S. and Gandhi, M.K. (2012) Expression profiling of Epstein-Barr virus-encoded microRNAs from paraffin-embedded formalin-fixed primary Epstein-Barr virus-positive B-cell lymphoma samples. Journal of Virological Methods, 184 1-2: 46-54. doi:10.1016/j.jviromet.2012.05.005 45   5 Cited 6 times in Scopus6 1
Goto, S., Vari, F., Lord, R., Edwards-Smith, C., Chiba, S., Kobayashi, S., Pan, T. L., Lin, Y. C., Chiang, K. C., Lai, C. Y., Tatsuma, T., Kitano, S. and Chen, C. L. (1999) Mechanisms of suppression in liver allograft rejection by LSF-1. Transplantation Proceedings, 31 1-2: 451-452. doi:10.1016/S0041-1345(98)01702-3 37   1 Cited 1 times in Scopus1 0
Gandhi, MK, Hertzberg, MS, Han, E, Seymour, JF, Hicks, R, Gill, DS, Keane, C, Crooks, P, Radford, K and Vari, F (2011). Monocytes Are Associated with Impaired T-Cell Immunity and Residual Interim-PET/CT Avidity After 4 Cycles of CHOP-R In Patients with High-Risk DLBCL. In: Blood. 53rd Annual Meeting and Exposition of the American-Society-of-Hematology (ASH), San Diego Ca, (1570-1570). Dec 10-13, 2011. 46   0
Vari F, Munster D.J., Hsu J.L., Rossetti T.R., Stephen Mahler, Gray, Peter P., Turtle C.J., Prue R.L. and Hart D.N. (2008) Practical blood dendritic cell vaccination for immunotherapy of multiple myeloma. British Journal Of Haematology, 143 3: 374-377. doi:10.1111/j.1365-2141.2008.07346.x 86   4 Cited 3 times in Scopus3 0
Radford, KJ, Vari, F and Hart, DNJ (2005) Vaccine strategies to treat lymphoproliferative disorders. Pathology, 37 6: 534-550. doi:10.1080/00313020500376462 4   12 Cited 12 times in Scopus12 0